Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

CARBAMAZEPINE

CARBAMAZEPINE

Standard Dose
200MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview CARBAMAZEPINE is listed in Drugs@FDA under application 201106 (ANDA).

Marketing status: Discontinued Active ingredient CARBAMAZEPINE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 200MG Sponsor TARO Submission history Latest submission status date: 2013-06-21 00:00:00.

Structured Monograph

Clinical summary

Approval overview CARBAMAZEPINE is listed in Drugs@FDA under application 201106 (ANDA). Marketing status: Discontinued Active ingredient CARBAMAZEPINE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 200MG Sponsor TARO Submission history Latest submission status date: 2013-06-21 00:00:00. Submission type: ORIG.

Monitoring

  • • Review priority: STANDARD
  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.